Medeze Group PCL
Medeze Group Public Company Limited engages in collection and storage of stem cells for use in medication in Thailand, Vietnam, Cambodia, and internationally. The company operates through four segments: Stem Cells; Natural Killer Cells; Others; and Sales of Products. It also provides sorting, cultivation, and development of stem cells; testing services to test the performance and count the number… Read more
Medeze Group PCL (MEDEZE) - Net Assets
Latest net assets as of : ฿- THB
Based on the latest financial reports, Medeze Group PCL (MEDEZE) has net assets worth ฿- THB as of .
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (฿-) and total liabilities (฿-). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | ฿- |
| % of Total Assets | 0% |
| Annual Growth Rate | N/A |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | N/A |
Medeze Group PCL - Net Assets Trend (None–None)
This chart illustrates how Medeze Group PCL's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Medeze Group PCL (None–None)
The table below shows the annual net assets of Medeze Group PCL from None to None.
| Year | Net Assets | Change |
|---|---|---|
| No yearly data available. | ||
Equity Component Analysis
This analysis shows how different components contribute to Medeze Group PCL's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- No equity composition insights available.
Medeze Group PCL Competitors by Market Cap
The table below lists competitors of Medeze Group PCL ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Kang Yong Electric Public Company Limited
BK:KYE
|
$44.05 Million |
|
TWC Enterprises Limited
PINK:CLKXF
|
$44.07 Million |
|
GiG Software PLC
ST:GIG-SDB
|
$44.07 Million |
|
Vanfund Urban Investment & Development Co Ltd
SHE:000638
|
$44.07 Million |
|
GAIAM-A
F:GA6
|
$44.02 Million |
|
Ambra SA
WAR:AMB
|
$44.01 Million |
|
Orient Europharma Co Ltd
TWO:4120
|
$44.01 Million |
|
MegaStudy Co. Ltd
KQ:072870
|
$44.01 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Medeze Group PCL's equity between the two most recent reporting periods.
Insufficient data available to analyze equity growth attribution.
Book Value vs Market Value Analysis
This analysis compares Medeze Group PCL's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Insufficient data available to analyze book value vs market value.
Capital Efficiency Dashboard
This dashboard shows how efficiently Medeze Group PCL utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Insufficient data available to analyze capital efficiency metrics.
Industry Comparison
This section compares Medeze Group PCL's net assets metrics with peer companies in the Medical Care Facilities industry.
Industry Context
- Industry: Medical Care Facilities
- Average net assets among peers: $2,892,225,945
- Average return on equity (ROE) among peers: 25.66%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Medeze Group PCL (MEDEZE) | ฿- | N/A | N/A | $44.02 Million |
| Aikchol Hospital Public Company Limited (AHC) | $1.55 Billion | 9.07% | 0.19x | $29.59 Million |
| Bangkok Chain Hospital Public Company Limited (BCH-R) | $6.40 Billion | 17.03% | 0.97x | $429.99 Million |
| Bumrungrad Hospital PCL (BH) | $13.10 Billion | 26.23% | 0.63x | $3.50 Billion |
| Chularat Hospital Public Company Limited (CHG) | $1.12 Billion | 29.84% | 0.38x | $205.50 Million |
| Chiang Mai Ram Medical Business Public Company Limited (CMR) | $5.27 Billion | 8.36% | 0.67x | $21.67 Million |
| Dental Corporation Public Company Limited (D) | $106.33 Million | 39.99% | 1.05x | $9.07 Million |
| Ekachai Medical Care Public Company Limited (EKH) | $953.94 Million | 16.80% | 0.15x | $56.66 Million |
| Genesis Fertility Center Public Company Limited (GFC) | $123.73 Million | 56.28% | 0.53x | $4.77 Million |
| Mukdahan International Hospital Public Company Limited (HANN) | $176.84 Million | 15.70% | 0.95x | $5.00 Million |
| Intermedical Care and Lab Hospital Public Company Limited (IMH) | $123.08 Million | 37.33% | 0.31x | $7.20 Million |